BACKGROUND
In 1931, Robert Frank, an American gynecologist, described a cyclical condition that plagued a number of his patients. He described this condition as premenstrual tension. However, it was not until 1953 that an English physician, Katherina Dalton , used the more common term of premen strual syndrome (Ginsburg, 1995) . In the ensuing years , PMS became an accepted medical condition. However, con siderable controversy still exists in the literature related to an actual definition, prevalence rates, etiology, diagnost ic criteria, and treatment (Kraemer, 1998) .
Premenstrual syndrome is commonly defined as the cyclic recurrence of physical, psychological, or behavioral symptoms appearing after ovulation that resolve within a few days after onset of menstruation (Korzekwa, 1997) . These monthly changes can be of sufficient severity to result in deterioration of interpersonal relationships and interference with normal activities (Reid, 1981) . However, the prevalence of PMS reported in the literature varies greatly. Hargrove (1982) reported an overall incidence of 50%, with a peak incidence of 60% in the third decade of life. Another study reported an 87% overall lifetime prevalence of premenstrual symptoms. However, when symptoms were categorized according to severity, only 13.4% of subjects reported moderatel y severe symptoms and 3.2% reported severe symptoms (Johnson, 1988) . Logue (1986) reported at least 40% of women experien ce some premen strual symptoms, with 2% to 10% reporting severe symptom s. The lack of consensus on a definition and diagno stic criteria for PMS has made it difficult to make generalizations from the published research (Kraemer, 1998) . Therefore, it is estimated 60% to 80% of women experience minor or isolated premenstrual symptoms, 20% to 50% report moderate symptoms, and 3% to 5% report symptoms so severe that it decreases their productivity (Fankhauser, 1996) .
It is the women with moderate to severe PMS symptoms who are likely to contact the nurse, either for Sommer (1973) concluded that women commonly report decreases in self confidence and work efficiency during the premenstrual period. As a result, accidents tend to occur more frequently during this time for some women. It has been shown that women physically slow down, resulting in a decrease in their productivity, prior to and during their menses. Kramer (1983) reported a Texas Instrument study, which found that during the premenstrual time, women were able to put together 75 components per hour. During the rest of the month, productivity increased to 100 components per hour. However, Johnson (1988) reported the mild to moderate symptoms reported by most women did not result in any functional impairment. Additional studies are needed on the smaller number of women who report severe symptoms. Because job performance can be affected, it is important for occupational health nurses to understand PMS is a real entity. By recognizing that a problem exists, nurses can provide tremendous aid to women suffering PMS. The nurse must also understand many PMS symptoms are not unique to PMS. It is the timing of the symptoms during the menstrual cycle that is important and provides the key to correct diagnosis and treatment (Keye, 1998) .
OVERVIEW OF THE MENSTRUAL CYCLE
The menstrual cycle is controlled by a complex feedback system involving the hypothalamus and the anterior pituitary gland (Fankhauser, 1996) . The average menstrual cycle lasts 28 days (range, 21 days to 35 days) and menses usually lasts 4 days to 6 days. The menstrual cycle is described in phases of ovarian function (i.e., follicular, FEBRUARY 2001, VOL. 49, NO.2 ovulatory, luteal) and by changes in the uterine endometrium (i.e., proliferative, secretory, menstrual phases). Day one of a menstrual cycle is the beginning of the follicular phase in the ovaries and the first day of the menstrual blood flow. The luteal, or premenstrual phase, is the time between ovulation and the beginning of menstrual blood flow. Therefore, women may experience symptoms starting 1 to 14 days prior to the beginning of menstruation. Symptoms typically resolve after menses begins.
SYMPTOMS OF PMS
More than 150 physical and behavioral symptoms have been associated with PMS-thus most women suffer from at least one symptom at some point in their lives. However, the most common complaints associated with PMS affecting job performance include headache, moodiness, irritability, back pain, insomnia, cramps, generalized muscle pains, and fatigue. The symptoms of PMS typically vary in nature and intensity from cycle to cycle and can be categorized as alterations in affective, cognitive (or performance), or somatic functioning (Daugherty, 1998) (see Table 1 ).
Premenstual syndrome can begin at menarche. However, signs and symptoms are more common in 30 year old to 40 year old women (Ugarriza, 1998) . Ramcharan (1992) reported that PMS symptoms showed a positive relationship to an increasing duration of reported stressful life experiences in the past year. One potential cause could be the increased stress of family and career responsibilities that occurs with age. Nader (1991) linked working outside the home with PMS. Additional factors associated with severe premenstrual symptoms included a family or personal history of depression, a history of migraines, having several children, and a high intake of alcohol or chocolate (Carlson, 1995) .
ETIOLOGY
Despite the recognition of factors associated with PMS, the exact cause of PMS remains undetermined (Keye, 1998 , Walker, 1998 , although several theories have been proposed. Initially PMS was thought to occur because of hormone imbalances related to the menstrual cycle (Ginsburg, 1995) . Much of the early research focused on hormones, namely estrogen and progesterone. Estrogen dominates the first half of the menstrual cycle, and progesterone is more abundant during the second half (Ginsburg, 1995) . It was believed the swing of these hormones in the weeks preceding menstruation and the monthly symptoms disappearing during pregnancy and at menopause were evidence of a hormonal cause. However, Rubinow (1988) found no difference in the level or patterns of secretion of progesterone, estrogen, or other hormones, and concluded PMS does not represent a simple hormone deficiency. The fluctuation of estrogen and progesterone are responsible for higher aldosterone levels in the luteal phase, which can result in sodium and fluid retention (Ugarriza, 1998) .
One theory links low levels of the neurotransmitter serotonin with PMS (Keye, 1998) . Estrogen and progesterone are known to alter the human brain's serotonin receptor concentration and serotonin metabolism. Rapkin (1987) conducted a study to analyze whole blood serotonin levels in subjects with well documented PMS. It was shown that blood serotonin levels in women with PMS are significantly lower than in controls during the last 10 days of the menstrual cycle. In humans, a decreased level of serotonin has been associated with depression, irritability, insomnia, and carbohydrate cravings, which are all common symptoms of PMS.
Sufferers of PMS have also been shown to possess low levels of endorphin production during the luteal phase of the menstrual cycle. This sudden decrease in endorphins, the body's natural opiate, can cause signs and symptoms similar to opiate withdrawal such as irritability, headache, and sleep disturbances (Ugarriza, 1998) .
Other proposed causes of PMS include hypoglycemia, calcium deficiency, an alteration in the metabolism of vitamin B6, or deficiencies of vitamin E or magnesium (Keye, 1998) . However, the most current theory is that a certain "vulnerability" exists for the development of premenstrual symptoms. This vulnerability may consist of one or more genetic, environmental, or behavioral factors triggered by either menstrually related hormones or by an unknown biological stimulus (Daugherty, 1998; Halbreich, 1999) . Though theories abound about the factors causing PMS, no single theory has been fully scientifically substantiated (Nader, 1991) . Because the etiology of PMS remains unknown, treatment goals are aimed at minimizing the women's symptoms and functional impairment, and optimizing their overall health. Successful treatment of PMS begins with a thorough assessment of the symptoms and their impact on daily life (Daugherty, 1998) .
DIAGNOSIS
The goal in the management of PMS is early diagnosis. One study investigating the treatment experiences 74 of women with PMS reported that subjects sought help for 5 or more years from a number of health care providers before receiving a diagnosis of PMS (Kraemer, 1998) . It has been estimated that 30% to 40% of all women seek medical help for premenstrual symptoms. Therefore, it is imperative for health care providers to consider the possibility of PMS as a diagnosis when taking the history of a female patient (Kraemer, 1998) . Because there are no symptoms unique to PMS, and no laboratory tests to diagnose or confirm the condition, clinicians must be knowledgeable about existing diagnostic criteria. The diagnosis of PMS is dependent on the timing and the cyclic characteristics of the symptoms (Kraemer, 1998) .
Many women believe they have PMS because they have physical symptoms although they experience little or no impact on relationships or daily activities (Ugarizza, 1998) . Therefore, careful history taking is the key to proper diagnosis. When women exhibit signs and symptoms suggesting PMS, detailed medical, menstrual, gynecologic, social, and occupational histories should be obtained, as well as a history of the premenstrual signs and symptoms. To diagnose PMS, the following criteria should be met (Ugarriza, 1998) :
• Consistent signs and symptoms.
• Occurrence of the symptoms in the luteal phase and resolution after the beginning of menses. • Ovulatory cycles.
• Sufficient severity to disrupt the woman's daily life.
An important diagnostic tool in identifying women with PMS is a prospective daily symptom rating calendar (Keye, 1998) . Because of the natural variability of the menstrual cycle, it is necessary for women to record their symptoms for a minimum of two cycles. Several instruments are available to record symptoms (see Figure) . Symptom rating calendars with patterns consistent with a diagnosis of PMS show an almost symptom free time from day 4 to day 12 of the menstrual cycle and a marked increase in the symptoms and the symptom severity in the last 7 days of the cycle (Keye, 1998) . The important key to making the diagnosis of PMS is that symptoms must have sufficient severity to interrupt normal activities.
Another step in the diagnosis of PMS is a complete physical examination. This is imperative because some health conditions have symptoms similar to PMS. In fact, 25% to 75% of women seeking medical assistance for PMS are diagnosed with another condition (Kraemer, 1998) . The physical examination is important to rule out other underlying disorders common in women such as hypothyroidism; anemia; hyperprolactinemia; vitamin deficiencies; autoimmune disorders; endometriosis; or cancer of the ovaries, uterus, cervix or breast (Fankhauser, 1996) . Depression and anxiety disorders must also be ruled out.
Laboratory tests are of little value in the diagnosis of PMS because the syndrome has no biologic or serologic abnormalities (Keye, 1998) . Laboratory studies should be performed, as indicated, to rule out other disorders with similar symptoms.
PMS Daily Symptom Checklist
You can find out whether or not it is likely that you have PMS by completing this daily symptom checklist. An important factor in the diagnosis of PMS is the cyclical characteristics of your symptoms. Part of the month may be symptom free. If anyone or more of the symptoms below apply to you on a given day, write the number of that symptom on the line for that day. Start logging your symptoms today and at the same time next month start Month 2. Because of the variability of cycles, it is important to do this checklist for 3 months.
(1) no symptoms (6) backache (11) dizziness (16) forgetfulness (21) migraine (2) abdominal bloating (7) breast tenderness (12) Month 2 
TREATMENT
Once the diagnosis of PMS is determined and symptoms have been carefully evaluated, the formulation of a client centered treatment plan can begin. The first step of treatment is consulting a knowledgeable and empathetic clinician who can validate the woman's experience and facilitate education about self help treatment strategies. An explanation of the prevalence and treatability of premenstrual symptoms has been shown to be therapeutic (Daugherty, 1998) . Because premenstrual symptoms tend to increase in severity until menopause, the cost and side effects of treatment options are important considerations. Many of the first line self care treatments the occupational health nurse can recommend to alleviate PMS symptoms also benefit general health and well being, are inexpensive, and have few side effects. These first line treatment modalities include lifestyle changes such as dietary modifications, nutritional supplements, aerobic exercise. and stress management skills. These treatments are summarized in Table 2 .
Although dietary changes have not yet proven effective in well controlled studies, clinical experiences support beneficial effects for some women. One study reported that dietary modifications were effective in almost 78% of women who made the changes (Singh, 1998) . Nutritional education should emphasize a well balanced diet consisting of frequent small meals high in complex carbohydrates. fruits. and vegetables (Johnson. 1998 , Keye, 1998 . Ugarriza, 1998 . Sodium and salty foods should be avoided to minimize fluid retention. Foods and beverages containing caffeine should be reduced or avoided if possible. Caffeine--often found in coffee, tea. soft drinks, chocolate, and some over the counter medications---can aggravate or increase PMS symptoms such as insomnia, headaches , breast tenderness. irritability, and anxiety (Keye, 1998) . Alcohol also should be avoided because it can worsen mood swings and depression (Keye, 1998) .
In addition to dietary modifications, nutritional supplement s in the form of vitamins and minerals are often recommended for the treatment of PMS. Vitamin B6, or pyridoxine. has been studied as a treatment of PMS for decades . This water soluble vitamin is a cofactor in serotonin metabolism and has been shown to alleviate depression, fatigue, and irritability associated with PMS. Abraham (1980) showed a lower symptom rating score in women during high dose vitamin B6 therapy. Barr (1984) also supported vitamin B6 as an effective form of treatment and recommended it be used as a first line therapy for PMS. However. vitamin B6 should only be taken in low doses (50 mg to 200mg/day) because an excess of the vitamin can cause neurotoxicity (Keye, 1998) .
Another nutritional supplement shown to produce significant improvement in PMS symptoms is calcium. Thys-Jacobs (1998) found that calcium supplementation effectively alleviated the luteal phase symptoms of PMS. The subjects experienced a 50% reduction in symptom scores with a significant benefit for symptoms such as depression. mood swings. headaches, and irritability. In addition, calcium has been shown to produce a significant improvement in water retention and pain related to the menstrual cycle. Because adequate calcium is important in premenopausal women for the prevention of osteoporosis, all women, especially women with PMS. should get 1,000 mg to 1.200 mg of calcium per day (Keye, 1998) .
Magnesium is another mineral under study for the treatment of PMS. Magnesium supplements at doses of 200 mg to 360 mg per day have been reported to improve mood and reduce fluid retention , weight gain, bloating , and breast tenderness (Walker, 1998) . Vitamin E in daily doses of 150 International Units (IU) to 400 IU has also been reported to reduce breast tenderness and swelling associated with PMS (Keye, 1998) . Studies are not yet conclusive, although many women have found these remedies useful. The number of studies of vitamin and mineral supplements for the treatment of PMS is limited and the mechanism of action is unknown for some. In general, these supplements are associated with minimal risk and cost (Carlson. 1995) .
In addition to vitamin and mineral supplements. numerous herbal treatments are marketed for PMS. For centurie s, the Chinese culture has used dong quai (also known as dang qui), a popular herbal treatment, as a remedy for PMS . Other herbs recommended for treating PMS include wild yam root, blue cohosh, black cohosh root, and ginger root. However, little scientific infonnation is available about herbal products and their efficacy in decreasing PMS symptom s (Fankhauser. 1996) .
Another product found in health food stores and marketed for PMS is evening primrose oil, made from the seed oil of the evening primrose flower. The oil contains gamma linolenic acid and vitamin E. Evening primrose oil has been reported to relieve breast tenderness associated with PMS (Kraemer, 1998) , as well as headache s, depression, and irritability (Ginsburg, 1995) .
Aerobic exercise is important for women experiencing PMS. Singh (1998) reported exercise appeared effective in more than 84% of women with PMS who used exercise to help their symptoms. Women engaging in moderate aerobic exercise at least three times per week had significantly fewer premenstrual symptoms than sedentary women (Johnson, 1995) . A regular exercise program not only can produce benefits for PMS symptoms, but can also improve general health. Exercise, by increasing endorphin production, is also a widely recognized treatment for depression and stress.
Many women claim insomnia related fatigue increases premenstrual signs and symptoms. Vigorous exercise and avoidance of caffeine can improve mood, increase alertness, and improve the sleep disturbances associated with PMS.
Women with PMS also may benefit from learning stress management skills for coping with premenstrual symptoms and stress in general. Carlson (1995) Individual counseling may be beneficial in identifying and managing particular areas of stress that may be a factor in increasing the severity of premenstrual symptoms (Ugarriza, 1998) . Group therapy can help women develop a sense of commonality to reduce isolation and increase the likelihood of implementing behavioral changes (Carlson, 1995) .
No single treatment for PMS has been found effective for all women. However, the majority of women who use self help treatment modalities for PMS report significant improvement (Jones, 1999) . A side benefit of these self help measures is the greater feeling of control women can have over PMS which is often perceived as an unpredictable and uncontrollable condition (Ginsburg, 1995) . If PMS symptoms do not improve after 3 months of lifestyle modifications, women should be referred to a knowledgeable health care provider for further treatment. Prescription drugs such as diuretics, nonsteroidal antiinflammatory drugs, and hormonal contraceptives have been used in the past to manage some PMS symptoms. However, selective serotonin reuptake inhibitors currently are becoming the preferred form of therapy for severe PMS (Singh, 1998) . Few direct comparison studies of drug versus nondrug therapies for PMS have been conducted. Thus, drug therapy should be reserved for women who have insufficient improvement of PMS symptoms by other measures (Daugherty, 1998) .
A variety of other medical, pharmacological, and surgical approaches to PMS exist. The majority of the approaches are tailored to a woman's symptoms and are beyond the scope of this article. More research is needed to determine which treatments are most effective in reducing symptoms. In addition, research is needed to determine if therapies currently reported as effective are effective for a large number of women over a long period of time (Krae-FEBRUARY 2001 , VOL. 49, NO.2 mer, 1998 . Additional research is also needed about PMS in the workplace and the effect of treatments on outcomes such as job attendance and work performance.
CONCLUSION
Premenstrual syndrome is a real condition resulting from a complex interaction of unknown physiologic and psychosocial stressors during the luteal phase of the menstrual cycle (Keye, 1998) . As a result, millions of women experience disturbing symptoms that interfere with personal relationships, social activities, and job performance. The cause of these symptoms remains unknown. Until the cause of PMS is understood and a standardized treatment is developed, the best way to conquer PMS is by understanding the symptoms and taking action to alleviate them. As knowledge of the etiology and treatment of PMS continues to grow through ongoing research, the occupational health nurse has an excellent opportunity to share this knowledge with women of all ages.
Because nurses in the workplace are capable of reaching a large number of women, it is important to maintain current knowledge about women's health issues. By sharing information about dietary modifications, nutritional supplements, aerobic exercise, and stress management skills, the nurse can help reduce the distress related to PMS. Without disturbing symptoms, millions of women can experience a better quality of life at home and in the workplace.
